Connect your AI

Sabra Healthcare SBRA Restricted Cash

Restricted Cash at other companies

American Healthcare REITAHR

$37.5M-9.4%

WelltowerWELL

$115.52M+6.5%

Omega Healthcare InvestorsOHI

$27.17M-24.8%

Healthpeak PropertiesDOC

$94.92M+39.6%

PACS GroupPACS

$25.73M+732%

Encompass Health CorporationEHC

$52.9M+95.9%

Other financials

Income statement

Revenue$221.8M+20.8%

Net income$40.9M+1.4%

EPS (diluted)$0.16-5.9%

Balance sheet

Cash & equivalents$116.5M+414%

Total debt$7.3M-9.6%

Total equity$2.8B+3.1%

Total assets$5.6B+6.8%

Cash flow

Operating cash flow$98.4M+22.5%

Valuation

Market cap$4.57B+16.7%

Profitability

Net margin19.2%-0.3pp

Returns & leverage

Return on equity5.7%+0.5pp

Debt / equity0×0.0×

Where this comes from

Reported directly by Sabra Healthcare in its filing.

Tagged under the XBRL concept us-gaap:RestrictedCashAndCashEquivalents.

The official record: Sabra Healthcare’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sabra Healthcare's restricted cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Sabra Healthcare's restricted cash?: Sabra Healthcare (SBRA) reported restricted cash of $6.92M in Q1 2026.
How has Sabra Healthcare's restricted cash changed year-over-year?: Sabra Healthcare's restricted cash increased by 10.8% year-over-year, from $6.24M to $6.92M.
What is the long-term trend for Sabra Healthcare's restricted cash?: Over 5 years (2020 to 2025), Sabra Healthcare's restricted cash has grown at a 0.5% compound annual growth rate (CAGR), from $6.45M to $6.6M.
What does restricted cash mean?: Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.